| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer
1 company
Stout Jay S serves as a Chief Technology Officer at IMVT. Across recent SEC filings that breaks down to 0 buys and 19 sells. Those positions are worth an estimated $8.4M at current prices.
Historically, Stout Jay S's trades have earned a middling insider score of 63/100 across 11 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +7.0%.
The biggest single holding is IMVT (~$8.4M) as Chief Technology Officer. The recent filings there lean toward selling, a net 77,892 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | IMVT Immunovant, Inc. | Chief Technology Officer | Sell | 2,195 | $23.59 | $51,780.05 | -1.5% | -38.7% | +12.7% | |
| Oct 23, 2024 | IMVT Immunovant, Inc. | Chief Technology Officer | Sell | 2,740 | $29.53 | $80,912.20 | -1.9% | -21.4% | -37.6% | |
| Jul 24, 2024 | IMVT Immunovant, Inc. | Chief Technology Officer | Sell | 2,813 | $27.76 | $78,088.88 | -1.9% | +5.9% | -34.4% | |
| Apr 24, 2024 | IMVT Immunovant, Inc. | Chief Technology Officer | Sell | 7,239 | $28.90 | $209,207.10 | -4.7% | -2.8% | -47.7% |